Characteristics of Severe Hypoglycemia Identified in T2DM

Share this content:
Characteristics of Severe Hypoglycemia Identified in T2DM
Characteristics of Severe Hypoglycemia Identified in T2DM

THURSDAY, July 19, 2018 (HealthDay News) -- For patients with type 2 diabetes, characteristics of those with severe hypoglycemia include having a prior diagnosis of non-severe hypoglycemia and hemoglobin A1c (HbA1c) <6 percent, according to a study published in the June issue of Diabetes Care.

Anita D. Misra-Hebert, M.D., from the Cleveland Clinic, and colleagues identified the number of severe hypoglycemic events and associated patient characteristics using the electronic medical record in the Cleveland Clinic Health System for 50,439 patients with type 2 diabetes.

The researchers observed an increase in the incidence proportion of severe hypoglycemia from 0.12 percent in 2006 to 0.31 percent in 2015. Patients with severe hypoglycemia had similar median HbA1c levels compared to patients who did not experience severe hypoglycemia. Compared to those without, more patients with severe hypoglycemia had a prior diagnosis of non-severe hypoglycemia (9 versus 2 percent). Increased odds for severe hypoglycemia were confirmed with insulin, sulfonylureas, increased number of diabetes medications, history of non-severe hypoglycemia (odds ratio 3.01), HbA1c <6 percent (odds ratio, 1.95), black race, and increased Charlson comorbidity index. With higher body mass index and use of metformin, dipeptidyl peptidase 4 inhibitors, and glucagon-like peptide 1 agonists, the odds of severe hypoglycemia were lower.

"Identifying patients at high risk at the point of care can allow for change in modifiable risk factors and prevention of severe hypoglycemia events," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »